Share on LinkedInShare on LinkedIn

ARTICLE · 01 DECEMBER 2014

Medtronic Secures Approval To Buy Covidien After Agreeing To Divestitures

Medical device maker Medtronic Inc. resolved the Competition Bureau’s concern that its acquisition of competitor Covidien PLC would reduce competition for the supply of drug-coated balloon catheters.

CanadaAntitrust/Competition Law

Medical device maker Medtronic Inc. resolved the Competition Bureau's concern that its acquisition of competitor Covidien PLC would reduce competition for the supply of drug-coated balloon catheters for the treatment of peripheral artery disease by agreeing to sell Covidien's drug-coated balloon catheter business to Spectanetics. Medtronic and Covidien signed a consent agreement with the Bureau.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from